Clinical Trial

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2023-10-31; most recent amendment 2025-10-29.
Status change: Recruiting → Active, Not Recruiting 2025-10-29
Status change: Not Yet Recruiting → Recruiting 2024-02-06
Trial Details
NCT Number NCT06116916
Lead Sponsor Kyowa Kirin Co., Ltd.
Conditions Diabetic Macular Edema (DME)
Enrollment 150 participants
Start Date 2024-01-09
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-30